| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | semaphorin receptor activity | 6.77e-06 | 12 | 64 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | aspartate:glutamate, proton antiporter activity | 1.01e-05 | 2 | 64 | 2 | GO:0000515 | |
| GeneOntologyMolecularFunction | 3-sulfino-L-alanine: proton, glutamate antiporter activity | 1.01e-05 | 2 | 64 | 2 | GO:0000514 | |
| GeneOntologyMolecularFunction | bent DNA binding | 3.03e-05 | 3 | 64 | 2 | GO:0003681 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation antiporter activity | 1.01e-04 | 5 | 64 | 2 | GO:0140848 | |
| GeneOntologyMolecularFunction | chemokine binding | 1.60e-04 | 33 | 64 | 3 | GO:0019956 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 3.30e-04 | 42 | 64 | 3 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 3.30e-04 | 42 | 64 | 3 | GO:0004812 | |
| GeneOntologyMolecularFunction | L-aspartate transmembrane transporter activity | 4.48e-04 | 10 | 64 | 2 | GO:0015183 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 4.53e-04 | 200 | 64 | 5 | GO:0008237 | |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 5.46e-04 | 11 | 64 | 2 | GO:0000099 | |
| GeneOntologyMolecularFunction | palmitoyl-(protein) hydrolase activity | 7.71e-04 | 13 | 64 | 2 | GO:0008474 | |
| GeneOntologyMolecularFunction | palmitoyl hydrolase activity | 8.98e-04 | 14 | 64 | 2 | GO:0098599 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.01e-03 | 138 | 64 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | C4-dicarboxylate transmembrane transporter activity | 1.03e-03 | 15 | 64 | 2 | GO:0015556 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 1.03e-03 | 15 | 64 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 1.85e-03 | 20 | 64 | 2 | GO:0015172 | |
| GeneOntologyMolecularFunction | ligase activity | 2.36e-03 | 174 | 64 | 4 | GO:0016874 | |
| GeneOntologyMolecularFunction | virus receptor activity | 2.57e-03 | 85 | 64 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 2.66e-03 | 86 | 64 | 3 | GO:0140272 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 3.13e-03 | 26 | 64 | 2 | GO:0070006 | |
| GeneOntologyMolecularFunction | peptide binding | 3.51e-03 | 318 | 64 | 5 | GO:0042277 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 4.43e-03 | 31 | 64 | 2 | GO:0005310 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 5.01e-03 | 33 | 64 | 2 | GO:0072349 | |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 8.89e-06 | 2 | 62 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | adenine metabolic process | 2.66e-05 | 3 | 62 | 2 | GO:0046083 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 2.66e-05 | 3 | 62 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 3.25e-05 | 301 | 62 | 7 | GO:0048588 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 3.66e-05 | 207 | 62 | 6 | GO:1990138 | |
| GeneOntologyBiologicalProcess | amino acid metabolic process | 6.05e-05 | 332 | 62 | 7 | GO:0006520 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to microtubule | 8.84e-05 | 5 | 62 | 2 | GO:1902817 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to microtubule | 8.84e-05 | 5 | 62 | 2 | GO:1902816 | |
| GeneOntologyBiologicalProcess | malate-aspartate shuttle | 8.84e-05 | 5 | 62 | 2 | GO:0043490 | |
| GeneOntologyBiologicalProcess | neuron projection development | JAK2 PLXNA3 MAP2 MYO7A CXCR4 HPRT1 VPS13A PLXNA4 HMGB1 MMP2 ITGA4 PREX1 PLXNA1 | 9.48e-05 | 1285 | 62 | 13 | GO:0031175 |
| GeneOntologyBiologicalProcess | cranial nerve morphogenesis | 1.21e-04 | 32 | 62 | 3 | GO:0021602 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.29e-04 | 648 | 62 | 9 | GO:0008015 | |
| GeneOntologyBiologicalProcess | trigeminal nerve morphogenesis | 1.32e-04 | 6 | 62 | 2 | GO:0021636 | |
| GeneOntologyBiologicalProcess | trigeminal nerve structural organization | 1.32e-04 | 6 | 62 | 2 | GO:0021637 | |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 1.54e-04 | 169 | 62 | 5 | GO:0046718 | |
| GeneOntologyBiologicalProcess | motor neuron axon guidance | 1.58e-04 | 35 | 62 | 3 | GO:0008045 | |
| GeneOntologyBiologicalProcess | gonadotrophin-releasing hormone neuronal migration to the hypothalamus | 1.85e-04 | 7 | 62 | 2 | GO:0021828 | |
| GeneOntologyBiologicalProcess | hypothalamic tangential migration using cell-axon interactions | 1.85e-04 | 7 | 62 | 2 | GO:0021856 | |
| GeneOntologyBiologicalProcess | branchiomotor neuron axon guidance | 1.85e-04 | 7 | 62 | 2 | GO:0021785 | |
| GeneOntologyBiologicalProcess | symbiont entry into host | 1.87e-04 | 176 | 62 | 5 | GO:0044409 | |
| GeneOntologyBiologicalProcess | central nervous system neuron development | 2.25e-04 | 99 | 62 | 4 | GO:0021954 | |
| GeneOntologyBiologicalProcess | olfactory nerve development | 2.46e-04 | 8 | 62 | 2 | GO:0021553 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D8 JAK2 PLXNA3 RASGRP3 AGTR1 PLXNA4 HMGB1 ST18 PREX1 PLXNA1 | 2.67e-04 | 878 | 62 | 10 | GO:0051336 |
| GeneOntologyBiologicalProcess | tRNA aminoacylation for protein translation | 2.73e-04 | 42 | 62 | 3 | GO:0006418 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 2.74e-04 | 299 | 62 | 6 | GO:0060560 | |
| GeneOntologyBiologicalProcess | hypothalamus cell migration | 3.16e-04 | 9 | 62 | 2 | GO:0021855 | |
| GeneOntologyBiologicalProcess | hypothalamus gonadotrophin-releasing hormone neuron differentiation | 3.16e-04 | 9 | 62 | 2 | GO:0021886 | |
| GeneOntologyBiologicalProcess | hypothalamus gonadotrophin-releasing hormone neuron development | 3.16e-04 | 9 | 62 | 2 | GO:0021888 | |
| GeneOntologyBiologicalProcess | circulatory system process | 3.23e-04 | 733 | 62 | 9 | GO:0003013 | |
| GeneOntologyBiologicalProcess | nerve development | 3.25e-04 | 109 | 62 | 4 | GO:0021675 | |
| GeneOntologyBiologicalProcess | tRNA aminoacylation | 3.35e-04 | 45 | 62 | 3 | GO:0043039 | |
| GeneOntologyBiologicalProcess | neuron development | JAK2 PLXNA3 MAP2 MYO7A CXCR4 HPRT1 VPS13A PLXNA4 HMGB1 MMP2 ITGA4 PREX1 PLXNA1 | 3.42e-04 | 1463 | 62 | 13 | GO:0048666 |
| GeneOntologyBiologicalProcess | amino acid activation | 3.58e-04 | 46 | 62 | 3 | GO:0043038 | |
| GeneOntologyBiologicalProcess | protein depalmitoylation | 3.94e-04 | 10 | 62 | 2 | GO:0002084 | |
| GeneOntologyBiologicalProcess | facial nerve structural organization | 3.94e-04 | 10 | 62 | 2 | GO:0021612 | |
| GeneOntologyBiologicalProcess | purine nucleobase biosynthetic process | 3.94e-04 | 10 | 62 | 2 | GO:0009113 | |
| GeneOntologyBiologicalProcess | L-aspartate transmembrane transport | 4.80e-04 | 11 | 62 | 2 | GO:0070778 | |
| GeneOntologyBiologicalProcess | cranial nerve formation | 4.80e-04 | 11 | 62 | 2 | GO:0021603 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | 5.02e-04 | 335 | 62 | 6 | GO:0043087 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 5.15e-04 | 52 | 62 | 3 | GO:0071526 | |
| GeneOntologyBiologicalProcess | positive regulation of angiogenesis | 5.21e-04 | 220 | 62 | 5 | GO:0045766 | |
| GeneOntologyBiologicalProcess | cell growth | 5.43e-04 | 625 | 62 | 8 | GO:0016049 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculature development | 5.54e-04 | 223 | 62 | 5 | GO:1904018 | |
| GeneOntologyBiologicalProcess | facial nerve morphogenesis | 5.75e-04 | 12 | 62 | 2 | GO:0021610 | |
| GeneOntologyBiologicalProcess | facial nerve development | 5.75e-04 | 12 | 62 | 2 | GO:0021561 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with host | 6.12e-04 | 228 | 62 | 5 | GO:0051701 | |
| GeneOntologyBiologicalProcess | axon development | 6.48e-04 | 642 | 62 | 8 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cranial nerve structural organization | 6.79e-04 | 13 | 62 | 2 | GO:0021604 | |
| GeneOntologyBiologicalProcess | trigeminal nerve development | 6.79e-04 | 13 | 62 | 2 | GO:0021559 | |
| GeneOntologyBiologicalProcess | macromolecule depalmitoylation | 7.90e-04 | 14 | 62 | 2 | GO:0098734 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to endosome | 7.90e-04 | 14 | 62 | 2 | GO:1905668 | |
| GeneOntologyBiologicalProcess | hypothalamus cell differentiation | 7.90e-04 | 14 | 62 | 2 | GO:0021979 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular associated smooth muscle cell proliferation | 8.62e-04 | 62 | 62 | 3 | GO:1904707 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | JAK2 PLXNA3 SP100 CXCR4 PLXNA4 HMGB1 MMP2 ITGA4 PREX1 PLXNA1 SCAI | 8.74e-04 | 1211 | 62 | 11 | GO:0030334 |
| GeneOntologyBiologicalProcess | chemotaxis | 8.92e-04 | 517 | 62 | 7 | GO:0006935 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 9.05e-04 | 375 | 62 | 6 | GO:0007162 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to endosome | 9.10e-04 | 15 | 62 | 2 | GO:1905666 | |
| GeneOntologyBiologicalProcess | AMP biosynthetic process | 9.10e-04 | 15 | 62 | 2 | GO:0006167 | |
| GeneOntologyBiologicalProcess | IMP biosynthetic process | 9.10e-04 | 15 | 62 | 2 | GO:0006188 | |
| GeneOntologyBiologicalProcess | taxis | 9.12e-04 | 519 | 62 | 7 | GO:0042330 | |
| GeneOntologyBiologicalProcess | GMP biosynthetic process | 1.04e-03 | 16 | 62 | 2 | GO:0006177 | |
| GeneOntologyBiologicalProcess | cranial nerve development | 1.08e-03 | 67 | 62 | 3 | GO:0021545 | |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in axon guidance | 1.17e-03 | 17 | 62 | 2 | GO:0048841 | |
| GeneOntologyBiologicalProcess | lipoprotein catabolic process | 1.17e-03 | 17 | 62 | 2 | GO:0042159 | |
| GeneOntologyBiologicalProcess | regulation of binding | 1.20e-03 | 396 | 62 | 6 | GO:0051098 | |
| GeneOntologyBiologicalProcess | negative regulation of vasoconstriction | 1.32e-03 | 18 | 62 | 2 | GO:0045906 | |
| GeneOntologyBiologicalProcess | nucleobase biosynthetic process | 1.32e-03 | 18 | 62 | 2 | GO:0046112 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | JAK2 PLXNA3 SP100 CXCR4 PLXNA4 HMGB1 MMP2 ITGA4 PREX1 PLXNA1 SCAI | 1.37e-03 | 1280 | 62 | 11 | GO:2000145 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | PLXNA3 SP100 MAP2 ERAP1 CXCR4 AGTR1 PLXNA4 HMGB1 WARS2 PLXNA1 | 1.43e-03 | 1090 | 62 | 10 | GO:0022603 |
| GeneOntologyBiologicalProcess | preganglionic parasympathetic fiber development | 1.47e-03 | 19 | 62 | 2 | GO:0021783 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 7.66e-06 | 13 | 64 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | gamma-delta T cell receptor complex | 1.37e-04 | 6 | 64 | 2 | GO:0042106 | |
| GeneOntologyCellularComponent | postsynaptic recycling endosome membrane | 1.37e-04 | 6 | 64 | 2 | GO:0098944 | |
| GeneOntologyCellularComponent | dynactin complex | 2.55e-04 | 8 | 64 | 2 | GO:0005869 | |
| GeneOntologyCellularComponent | postsynaptic endosome membrane | 4.99e-04 | 11 | 64 | 2 | GO:0098895 | |
| GeneOntologyCellularComponent | aminoacyl-tRNA synthetase multienzyme complex | 5.97e-04 | 12 | 64 | 2 | GO:0017101 | |
| GeneOntologyCellularComponent | postsynaptic recycling endosome | 7.04e-04 | 13 | 64 | 2 | GO:0098837 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.50e-03 | 161 | 64 | 4 | GO:0005875 | |
| Domain | Plexin_cytopl | 2.75e-06 | 9 | 61 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 2.75e-06 | 9 | 61 | 3 | IPR013548 | |
| Domain | Plexin | 2.75e-06 | 9 | 61 | 3 | IPR031148 | |
| Domain | Arp1 | 1.05e-05 | 2 | 61 | 2 | IPR029909 | |
| Domain | aa-tRNA-synth_I_CS | 2.61e-05 | 18 | 61 | 3 | IPR001412 | |
| Domain | AA_TRNA_LIGASE_I | 3.09e-05 | 19 | 61 | 3 | PS00178 | |
| Domain | IPT | 9.17e-05 | 27 | 61 | 3 | SM00429 | |
| Domain | TIG | 1.40e-04 | 31 | 61 | 3 | PF01833 | |
| Domain | Sema | 1.40e-04 | 31 | 61 | 3 | SM00630 | |
| Domain | Semap_dom | 1.40e-04 | 31 | 61 | 3 | IPR001627 | |
| Domain | Sema | 1.40e-04 | 31 | 61 | 3 | PF01403 | |
| Domain | SEMA | 1.40e-04 | 31 | 61 | 3 | PS51004 | |
| Domain | PSI | 1.54e-04 | 32 | 61 | 3 | PF01437 | |
| Domain | IPT | 1.54e-04 | 32 | 61 | 3 | IPR002909 | |
| Domain | Plexin_repeat | 1.54e-04 | 32 | 61 | 3 | IPR002165 | |
| Domain | CXCR4/ACKR2 | 2.18e-04 | 7 | 61 | 2 | IPR001277 | |
| Domain | ZINC_PROTEASE | 2.96e-04 | 98 | 61 | 4 | PS00142 | |
| Domain | HMG_box_2 | 3.72e-04 | 9 | 61 | 2 | PF09011 | |
| Domain | Hydrolase_4 | 3.72e-04 | 9 | 61 | 2 | IPR022742 | |
| Domain | Hydrolase_4 | 3.72e-04 | 9 | 61 | 2 | PF12146 | |
| Domain | Rossmann-like_a/b/a_fold | 3.73e-04 | 43 | 61 | 3 | IPR014729 | |
| Domain | - | 3.73e-04 | 43 | 61 | 3 | 3.40.50.620 | |
| Domain | PSI | 3.99e-04 | 44 | 61 | 3 | IPR016201 | |
| Domain | PSI | 4.55e-04 | 46 | 61 | 3 | SM00423 | |
| Domain | HAT | 4.64e-04 | 10 | 61 | 2 | IPR003107 | |
| Domain | HAT | 4.64e-04 | 10 | 61 | 2 | SM00386 | |
| Domain | Peptidase_M1 | 6.78e-04 | 12 | 61 | 2 | IPR001930 | |
| Domain | Peptidase_M1 | 8.00e-04 | 13 | 61 | 2 | PF01433 | |
| Domain | - | 8.00e-04 | 13 | 61 | 2 | 2.10.10.10 | |
| Domain | Peptidase_M1_N | 8.00e-04 | 13 | 61 | 2 | IPR014782 | |
| Domain | FN_type2_col-bd | 9.31e-04 | 14 | 61 | 2 | IPR000562 | |
| Domain | FN2_2 | 9.31e-04 | 14 | 61 | 2 | PS51092 | |
| Domain | fn2 | 9.31e-04 | 14 | 61 | 2 | PF00040 | |
| Domain | FN2_1 | 9.31e-04 | 14 | 61 | 2 | PS00023 | |
| Domain | FN2 | 9.31e-04 | 14 | 61 | 2 | SM00059 | |
| Domain | Actin_CS | 1.22e-03 | 16 | 61 | 2 | IPR004001 | |
| Domain | ACTINS_2 | 1.38e-03 | 17 | 61 | 2 | PS00432 | |
| Domain | Actin/actin-like_CS | 1.55e-03 | 18 | 61 | 2 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.73e-03 | 19 | 61 | 2 | PS01132 | |
| Domain | Rho_GTPase_activation_prot | 2.99e-03 | 88 | 61 | 3 | IPR008936 | |
| Domain | Aden_trnslctor | 3.76e-03 | 28 | 61 | 2 | IPR002113 | |
| Domain | ZnMc | 4.02e-03 | 29 | 61 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 4.02e-03 | 29 | 61 | 2 | IPR006026 | |
| Domain | Actin | 4.59e-03 | 31 | 61 | 2 | IPR004000 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 4.39e-06 | 9 | 54 | 3 | MM15030 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.88e-05 | 14 | 54 | 3 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.88e-05 | 14 | 54 | 3 | M7578 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 2.34e-05 | 15 | 54 | 3 | MM15031 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 2.87e-05 | 16 | 54 | 3 | M16498 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 2.87e-05 | 16 | 54 | 3 | M8245 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.46e-04 | 27 | 54 | 3 | M47755 | |
| Pathway | KEGG_BASE_EXCISION_REPAIR | 3.19e-04 | 35 | 54 | 3 | M5500 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGII_AT1R_NOX2_SIGNALING_PATHWAY | 3.97e-04 | 8 | 54 | 2 | M47780 | |
| Pathway | REACTOME_MALATE_ASPARTATE_SHUTTLE | 5.10e-04 | 9 | 54 | 2 | M48269 | |
| Pathway | REACTOME_MALATE_ASPARTATE_SHUTTLE | 5.10e-04 | 9 | 54 | 2 | MM17242 | |
| Pathway | KEGG_AMINOACYL_TRNA_BIOSYNTHESIS | 5.11e-04 | 41 | 54 | 3 | M14691 | |
| Pathway | REACTOME_TRNA_AMINOACYLATION | 5.49e-04 | 42 | 54 | 3 | M456 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 5.88e-04 | 43 | 54 | 3 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 6.73e-04 | 45 | 54 | 3 | M47670 | |
| Pathway | REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM | 7.75e-04 | 11 | 54 | 2 | M27836 | |
| Pathway | REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM | 9.27e-04 | 12 | 54 | 2 | MM15556 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 9.72e-04 | 51 | 54 | 3 | MM14967 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 11306810 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 2.61e-08 | 4 | 66 | 3 | 25518740 | |
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 2.27e-07 | 7 | 66 | 3 | 19063725 | |
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 2.27e-07 | 7 | 66 | 3 | 19655386 | |
| Pubmed | 3.63e-07 | 8 | 66 | 3 | 15661641 | ||
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 3.63e-07 | 8 | 66 | 3 | 22368082 | |
| Pubmed | 5.44e-07 | 9 | 66 | 3 | 19909241 | ||
| Pubmed | Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development. | 7.76e-07 | 10 | 66 | 3 | 18804103 | |
| Pubmed | Transient microglial absence assists postmigratory cortical neurons in proper differentiation. | 1.07e-06 | 11 | 66 | 3 | 32242005 | |
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 1.42e-06 | 12 | 66 | 3 | 24179230 | |
| Pubmed | 1.42e-06 | 12 | 66 | 3 | 23991118 | ||
| Pubmed | 1.42e-06 | 12 | 66 | 3 | 25839327 | ||
| Pubmed | 1.42e-06 | 12 | 66 | 3 | 31690636 | ||
| Pubmed | 1.42e-06 | 12 | 66 | 3 | 28407732 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 1.42e-06 | 12 | 66 | 3 | 21270798 | |
| Pubmed | 1.84e-06 | 13 | 66 | 3 | 11604131 | ||
| Pubmed | Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. | 1.84e-06 | 13 | 66 | 3 | 22723296 | |
| Pubmed | Functional assembly of accessory optic system circuitry critical for compensatory eye movements. | 1.84e-06 | 13 | 66 | 3 | 25959730 | |
| Pubmed | 1.84e-06 | 13 | 66 | 3 | 10520995 | ||
| Pubmed | A midline switch of receptor processing regulates commissural axon guidance in vertebrates. | 2.34e-06 | 14 | 66 | 3 | 20159958 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 25410934 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 1973682 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 3486244 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 21656184 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 7696711 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 9126983 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 3871915 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 3375073 | ||
| Pubmed | Structure, organization, and somatic rearrangement of T cell gamma genes. | 3.55e-06 | 2 | 66 | 2 | 3917858 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 25349153 | ||
| Pubmed | Age-related changes in expression of CTL2/SLC44A2 and its isoforms in the mouse inner ear. | 3.55e-06 | 2 | 66 | 2 | 21986210 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 8244371 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 17213189 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 14691262 | ||
| Pubmed | A gammaGT-AT1A receptor transgene protects renal cortical structure in AT1 receptor-deficient mice. | 3.55e-06 | 2 | 66 | 2 | 15306694 | |
| Pubmed | CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL. | 3.55e-06 | 2 | 66 | 2 | 21093051 | |
| Pubmed | Allelic differences in TCR gamma-chains alter gamma delta T cell antigen reactivity. | 3.55e-06 | 2 | 66 | 2 | 8046225 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 23018206 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 36967723 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 27132995 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 12084073 | ||
| Pubmed | Physical linkage of mouse Tcrg-V genes. II. Regulatory features of the Vg4-Vg3 intergenic region. | 3.55e-06 | 2 | 66 | 2 | 8119740 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 26155911 | ||
| Pubmed | Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma. | 3.55e-06 | 2 | 66 | 2 | 32314796 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 24619647 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 10369257 | ||
| Pubmed | New T-cell receptor gamma haplotypes in wild mice and evidence for limited Tcrg-V gene polymorphism. | 3.55e-06 | 2 | 66 | 2 | 8420824 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 8550103 | ||
| Pubmed | 3.59e-06 | 16 | 66 | 3 | 17356169 | ||
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 3.59e-06 | 16 | 66 | 3 | 18489001 | |
| Pubmed | 4.35e-06 | 17 | 66 | 3 | 11683995 | ||
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 4.35e-06 | 17 | 66 | 3 | 17626059 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PPP1R8 ACTR1B ACTR1A SLC9C1 MYO7A CXCR4 IARS1 HPRT1 HMGB1 QARS1 TSPYL4 HIF1AN | 6.33e-06 | 1321 | 66 | 12 | 27173435 |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 27397516 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 11171103 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 31467427 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 29850505 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 28440514 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 30904607 | ||
| Pubmed | Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines. | 1.06e-05 | 3 | 66 | 2 | 16141352 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 31562296 | ||
| Pubmed | The prognostic value of CXCR4, MMP-2 and MMP-9 in tongue squamous carcinoma. | 1.06e-05 | 3 | 66 | 2 | 31263828 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 18523013 | ||
| Pubmed | Distribution of neuronal KCC2a and KCC2b isoforms in mouse CNS. | 1.06e-05 | 3 | 66 | 2 | 24639001 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 26499944 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 19144663 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 11152457 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 28716707 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 2879283 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 24239175 | ||
| Pubmed | Novel BMP1, CRTAP, and SERPINF1 variants causing autosomal recessive osteogenesis imperfecta. | 1.06e-05 | 3 | 66 | 2 | 35703132 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 15955449 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 8806646 | ||
| Pubmed | Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma. | 1.06e-05 | 3 | 66 | 2 | 32896760 | |
| Pubmed | Langerhans cells are not required for epidermal Vgamma3 T cell homeostasis and function. | 1.06e-05 | 3 | 66 | 2 | 21486908 | |
| Pubmed | AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. | 1.06e-05 | 3 | 66 | 2 | 21459331 | |
| Pubmed | Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. | 1.06e-05 | 3 | 66 | 2 | 7746328 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 18348195 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 18625214 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 23308188 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 28544312 | ||
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 1.06e-05 | 3 | 66 | 2 | 11241833 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 31679624 | ||
| Pubmed | SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia. | 1.06e-05 | 3 | 66 | 2 | 18448868 | |
| Pubmed | Identification of the cytoplasmic domains of CXCR4 involved in Jak2 and STAT3 phosphorylation. | 1.06e-05 | 3 | 66 | 2 | 15615703 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 23478800 | ||
| Pubmed | Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. | 1.06e-05 | 3 | 66 | 2 | 17964871 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 20138877 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 29153094 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 17486447 | ||
| Pubmed | A semaphorin code defines subpopulations of spinal motor neurons during mouse development. | 1.28e-05 | 24 | 66 | 3 | 15869472 | |
| Pubmed | A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis. | 1.28e-05 | 24 | 66 | 3 | 28893946 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACTR1A CRNKL1 RNPEP CXCR4 IARS1 HPRT1 SLC25A13 GART HMGB1 IDE QARS1 PLXNA1 | 1.35e-05 | 1425 | 66 | 12 | 30948266 |
| Pubmed | 2.07e-05 | 28 | 66 | 3 | 18617019 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 30018141 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 14701727 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 21909361 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 16672549 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 15721238 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 19109194 | ||
| Interaction | SEMA5A interactions | 1.01e-06 | 7 | 63 | 3 | int:SEMA5A | |
| Interaction | SEMA5B interactions | 1.29e-05 | 15 | 63 | 3 | int:SEMA5B | |
| Cytoband | 9q21 | 1.11e-04 | 11 | 66 | 2 | 9q21 | |
| Cytoband | 7p14 | 8.63e-04 | 30 | 66 | 2 | 7p14 | |
| GeneFamily | Plexins | 1.37e-06 | 9 | 47 | 3 | 683 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 1.55e-05 | 19 | 47 | 3 | 131 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 5.74e-05 | 29 | 47 | 3 | 396 | |
| GeneFamily | Aminopeptidases|CD molecules | 8.77e-04 | 17 | 47 | 2 | 104 | |
| GeneFamily | T cell receptor gamma locus at 7p14 | 1.48e-03 | 22 | 47 | 2 | 375 | |
| GeneFamily | Abhydrolase domain containing | 1.48e-03 | 22 | 47 | 2 | 4 | |
| GeneFamily | EF-hand domain containing | 2.48e-03 | 219 | 47 | 4 | 863 | |
| GeneFamily | C-type lectin domain family | 6.64e-03 | 47 | 47 | 2 | 494 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 7.48e-03 | 50 | 47 | 2 | 1293 | |
| GeneFamily | Solute carriers | 1.91e-02 | 395 | 47 | 4 | 752 | |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP | 3.78e-06 | 165 | 66 | 6 | M6880 | |
| Coexpression | BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP | 1.27e-05 | 204 | 66 | 6 | M34006 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 3.50e-05 | 362 | 66 | 7 | M39176 | |
| Coexpression | COLDREN_GEFITINIB_RESISTANCE_UP | 6.67e-05 | 86 | 66 | 4 | M18134 | |
| Coexpression | OSMAN_BLADDER_CANCER_UP | 6.77e-05 | 402 | 66 | 7 | M5275 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | 8.05e-05 | 175 | 66 | 5 | M6694 | |
| Coexpression | WALLACE_PROSTATE_CANCER_RACE_UP | 1.15e-04 | 303 | 66 | 6 | M10319 | |
| Coexpression | LTE2_UP.V1_DN | 1.34e-04 | 195 | 66 | 5 | M2721 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS | 1.35e-04 | 312 | 66 | 6 | M39161 | |
| Coexpression | GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN | 1.47e-04 | 199 | 66 | 5 | M3093 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP | 1.51e-04 | 200 | 66 | 5 | M9455 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP | 1.51e-04 | 200 | 66 | 5 | M3407 | |
| Coexpression | GSE27786_LSK_VS_CD8_TCELL_DN | 1.51e-04 | 200 | 66 | 5 | M4750 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKTCELL_UP | 1.51e-04 | 200 | 66 | 5 | M4787 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 1.51e-04 | 200 | 66 | 5 | M7417 | |
| Coexpression | VALK_AML_WITH_FLT3_ITD | 1.52e-04 | 41 | 66 | 3 | M10010 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 1.67e-04 | 465 | 66 | 7 | M39066 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-07 | 185 | 65 | 6 | 19fa853f6f746ccf232a343b3c9c7a5e55800409 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.86e-07 | 193 | 65 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-07 | 194 | 65 | 6 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-07 | 197 | 65 | 6 | b803c07072a7860497d07a3be358a28a24359cbf | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-06 | 150 | 65 | 5 | fdbfc8f743cf848978cf0488493f6df60be53982 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.75e-06 | 175 | 65 | 5 | 97a58bc6ed2e8e359283d4214172c990c6e3755e | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 5.91e-06 | 176 | 65 | 5 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.24e-06 | 178 | 65 | 5 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-06 | 179 | 65 | 5 | 51872338e54c5f3e42ca9f1c4cf1e8b0cb84afcc | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-06 | 179 | 65 | 5 | 1b979e0203a2ddfe98bf6c2c80c4af1ba437a80f | |
| ToppCell | ILEUM-non-inflamed-(1)_T_(gd)|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.59e-06 | 180 | 65 | 5 | 44c37644973c4fc555dc966f8cfe1f4f81fef300 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.33e-06 | 184 | 65 | 5 | 33db879e629821fb75684e60f8f0749cf9623bdd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.73e-06 | 186 | 65 | 5 | e152bdd837366e3e0b8bcfdb4d53f0685f2e803a | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.14e-06 | 188 | 65 | 5 | ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-06 | 188 | 65 | 5 | 0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.35e-06 | 189 | 65 | 5 | 620d5a71b8cb6288540e2d2d848b9d4d66c1226f | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 8.57e-06 | 190 | 65 | 5 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.79e-06 | 191 | 65 | 5 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 9.01e-06 | 192 | 65 | 5 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.24e-06 | 193 | 65 | 5 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-06 | 193 | 65 | 5 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-06 | 193 | 65 | 5 | 12f1333f11e6c262954ad7912d8fd2962ab06d25 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.24e-06 | 193 | 65 | 5 | 81fdb825245cd346bf7277086b95d72a47bded73 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.48e-06 | 194 | 65 | 5 | bf2480acec5612cd8a3c33d3e7a98176dc6c9091 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 9.48e-06 | 194 | 65 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | IIF-Lymphocyte-T_NK-CD8_TEM|IIF / Disease, Lineage and Cell Type | 9.48e-06 | 194 | 65 | 5 | f4f7c85963ba52ee7ca2ef5657e60680fe6332fe | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.48e-06 | 194 | 65 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.48e-06 | 194 | 65 | 5 | ae5357e2a276473cde1fc8c43acaf9f69da35fd7 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.48e-06 | 194 | 65 | 5 | 3a0b8b5d0354c43da57bb951cd8ba878363c3de5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-06 | 195 | 65 | 5 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.72e-06 | 195 | 65 | 5 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.72e-06 | 195 | 65 | 5 | 36c784709ee32174e05b457500339c3b8eee3244 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 197 | 65 | 5 | 57dafb3047745a44b2345b8036e159c3641d496e | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 197 | 65 | 5 | 9791923feefbd78810242113ad2a08ce4c2bb4f2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 197 | 65 | 5 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 197 | 65 | 5 | a07e1a9b95c9f8a09452cbfe5a9f06648f66e29e | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-05 | 198 | 65 | 5 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 65 | 5 | 09e0b45529fa9d5fc86da1747b3fb3a238a09aa6 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 65 | 5 | b947ecaf912d97869f6df32736b8c2b2dd695d66 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 65 | 5 | 5f41906cf1585e09b150a84364d47c3e466dc5b7 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.10e-05 | 200 | 65 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 65 | 5 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-CD8+_Tem|IIF / Disease, condition lineage and cell class | 1.10e-05 | 200 | 65 | 5 | d75582d50f178ec67490fc298d42b10e18640c5a | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 65 | 5 | 13d8c5d65d7f900979319433e7044efa6d06de20 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 65 | 5 | 66fb892bda1d29e67a65717e85f2ec221f520b2a | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 65 | 5 | 893bb7c25ad7c6589a4c7c0364c2ace666e9b4be | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 65 | 5 | dbbc7e16929e744b48017da068479a6046e99cf6 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 65 | 5 | 27f498bcd706d0751091662996795b5270e46f14 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 65 | 5 | 9ef322486e46e4ff05a8cbe06cf8019e996c94b3 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.05e-05 | 131 | 65 | 4 | cc5b5afab8622e98f673fa116a226d930c295327 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.68e-05 | 149 | 65 | 4 | 2a7f71da51c85e04de2123164914122480e60d66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.04e-05 | 151 | 65 | 4 | 0cc2f4aec3dae4603fa831f22c40f897e68b34e2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.04e-05 | 151 | 65 | 4 | b545823113a3450c5f841f7de48bf0937593544f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD8-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.99e-05 | 156 | 65 | 4 | b0511ce81c446482339def3a0945fcbba6da35d0 | |
| ToppCell | COVID-19-Myeloid-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 7.99e-05 | 156 | 65 | 4 | a07a9096799e4ba663841c70035b4b32c1fda4f9 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.99e-05 | 156 | 65 | 4 | 71f49db7d6da5533ecfcd4eacb50ecf1f30ee712 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-gdT|ICU-NoSEP / Disease, Lineage and Cell Type | 8.81e-05 | 160 | 65 | 4 | 2798c5bd971407f27dd4d3a4831d63d9c88003c3 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.02e-05 | 161 | 65 | 4 | 6d9907e2949a742c0933128fde57832a9ca5f77c | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.24e-05 | 162 | 65 | 4 | 74cd0de957fdbe527656befd61f67d6814ce9e98 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 164 | 65 | 4 | 1250876abd7311f86730e5b9c03c3610cc2ff6d3 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 164 | 65 | 4 | fa0d77b648cde5e42b9394e877168c80de238bde | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 164 | 65 | 4 | 649e42d9cfdec2f7771d1e938b516e46e7d07078 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 164 | 65 | 4 | ba85f7b21ae34e285d286ada24715885ca6329f7 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 164 | 65 | 4 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | Dendritic_Cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.02e-04 | 166 | 65 | 4 | fbeb74b98b58085de323f744b18d4a8f7b22d5d4 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 166 | 65 | 4 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 168 | 65 | 4 | 80233a13135fd159f5764336a1fe67fba237776b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 168 | 65 | 4 | 318fa1bd5a9d6ae95042517ef30515b6416b61e4 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.06e-04 | 168 | 65 | 4 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 168 | 65 | 4 | 75b3998aff704a77895ee3723813d8a3819b7cec | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.06e-04 | 168 | 65 | 4 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-04 | 169 | 65 | 4 | f06118754fa62c580b4bcbecff6f9e5fdc2106a0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 169 | 65 | 4 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 169 | 65 | 4 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 170 | 65 | 4 | 02f0be0aab8ba2d35a83238609352ef3677511c9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 172 | 65 | 4 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 172 | 65 | 4 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | URO-Lymphocyte-T_NK-gdT|URO / Disease, Lineage and Cell Type | 1.16e-04 | 172 | 65 | 4 | 97b1eb95234639fcaa5ea3c4ba7ec2f4eb929dbf | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-04 | 173 | 65 | 4 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 173 | 65 | 4 | 4e9b6c71030ae0d63d54e7255e4a10b25970fcc4 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 174 | 65 | 4 | 7be0c6248e77f2d0260b852b01e17892f7828f1b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 174 | 65 | 4 | 47e308a777c927ae69ed344cb3dd8561bf2c48a5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 174 | 65 | 4 | a92c745d20633909db0f08effa13fc738fda79a6 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-04 | 175 | 65 | 4 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | 356C-Lymphocytic-ILC|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-04 | 175 | 65 | 4 | 7fa8330ce813c48bd332be618909e5ec8d0f5d7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 175 | 65 | 4 | 2f43883d7c89f09b0579a390a7431f1f9b832582 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 175 | 65 | 4 | da92eb8af0c7c65fed4a1d960708240f35dd997d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 176 | 65 | 4 | dbc4f64cd39b229f2355ca1d0215cc7f6a767dce | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 176 | 65 | 4 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 176 | 65 | 4 | 9399e174d14e81cc977fcb48facf844ee6726603 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 176 | 65 | 4 | 238244294d08975df6bfa26b2b437db3654408ae | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class | 1.30e-04 | 177 | 65 | 4 | 34e9455790bae905dd91923792f4109d18b7686e | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 1.33e-04 | 178 | 65 | 4 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | IIF-Lymphocyte-T_NK-gdT|IIF / Disease, Lineage and Cell Type | 1.33e-04 | 178 | 65 | 4 | 3344d1328fd9c570c3a4b2629edec627a442d0e0 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 178 | 65 | 4 | 40df4bb0978e5e5568c52ad4a5881ea0cdc6941d | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 179 | 65 | 4 | f93e81a3fd94adedb24a9db4ac1d53e275bbf8b5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 179 | 65 | 4 | 874a9afa91774221c9c1775aa4968ba0aea7b554 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.36e-04 | 179 | 65 | 4 | c1f7c1b73dc1cb2135da390b16d3b5bd645cd724 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 179 | 65 | 4 | dd3cf8fd10dc257d933a7f45860dc2e244c158b7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 180 | 65 | 4 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| Computational | Genes in the cancer module 371. | 1.45e-04 | 26 | 43 | 3 | MODULE_371 | |
| Drug | Formyl | 3.83e-07 | 238 | 65 | 8 | CID000123370 | |
| Drug | arabinosyladenine | AKAP6 ACTR1B ACTR1A CXCR4 IARS1 HPRT1 GART MMP2 QARS1 WARS2 OPRL1 | 9.46e-06 | 762 | 65 | 11 | CID000000191 |
| Drug | Fumadil B | 1.72e-05 | 54 | 65 | 4 | CID000003430 | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.87e-05 | 193 | 65 | 6 | 997_UP | |
| Drug | Betulin [473-98-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.98e-05 | 195 | 65 | 6 | 3513_DN | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 2.29e-05 | 200 | 65 | 6 | 4625_DN | |
| Drug | Ap3U | 2.40e-05 | 3 | 65 | 2 | CID003082313 | |
| Disease | common bile duct disease (implicated_via_orthology) | 4.78e-06 | 2 | 65 | 2 | DOID:4137 (implicated_via_orthology) | |
| Disease | atherosclerosis (biomarker_via_orthology) | 1.13e-05 | 20 | 65 | 3 | DOID:1936 (biomarker_via_orthology) | |
| Disease | citrullinemia (implicated_via_orthology) | 1.43e-05 | 3 | 65 | 2 | DOID:9273 (implicated_via_orthology) | |
| Disease | blood rubidium measurement | 2.56e-05 | 26 | 65 | 3 | EFO_0021529 | |
| Disease | intrahepatic cholestasis (implicated_via_orthology) | 2.86e-05 | 4 | 65 | 2 | DOID:1852 (implicated_via_orthology) | |
| Disease | congestive heart failure (implicated_via_orthology) | 1.02e-04 | 41 | 65 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | MRC1 ACTR1B ACTR1A MAP2 CXCR4 RASGRP3 CNKSR2 HIF1AN WARS2 SCAI | 1.09e-04 | 1069 | 65 | 10 | EFO_0004346 |
| Disease | nephritis (implicated_via_orthology) | 2.13e-04 | 10 | 65 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | Osteogenesis imperfecta type III (disorder) | 2.59e-04 | 11 | 65 | 2 | C0268362 | |
| Disease | focal segmental glomerulosclerosis (biomarker_via_orthology) | 3.11e-04 | 12 | 65 | 2 | DOID:1312 (biomarker_via_orthology) | |
| Disease | myocardial infarction (implicated_via_orthology) | 4.23e-04 | 66 | 65 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | Neuralgia, Supraorbital | 5.62e-04 | 16 | 65 | 2 | C0038870 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 5.62e-04 | 16 | 65 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 5.62e-04 | 16 | 65 | 2 | C0423711 | |
| Disease | Neuralgia | 5.62e-04 | 16 | 65 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 5.62e-04 | 16 | 65 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 5.62e-04 | 16 | 65 | 2 | C0234249 | |
| Disease | Paroxysmal Nerve Pain | 5.62e-04 | 16 | 65 | 2 | C0751373 | |
| Disease | Nerve Pain | 5.62e-04 | 16 | 65 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 5.62e-04 | 16 | 65 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 5.62e-04 | 16 | 65 | 2 | C0042656 | |
| Disease | myopia (is_implicated_in) | 5.62e-04 | 16 | 65 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 5.91e-04 | 74 | 65 | 3 | DOID:3748 (is_marker_for) | |
| Disease | Rheumatoid Arthritis | 5.98e-04 | 174 | 65 | 4 | C0003873 | |
| Disease | Colorectal Carcinoma | 8.81e-04 | 702 | 65 | 7 | C0009402 | |
| Disease | Osteogenesis imperfecta | 9.77e-04 | 21 | 65 | 2 | cv:C0029434 | |
| Disease | periodontitis (biomarker_via_orthology) | 9.77e-04 | 21 | 65 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | carotid artery disease (is_implicated_in) | 1.07e-03 | 22 | 65 | 2 | DOID:3407 (is_implicated_in) | |
| Disease | Down syndrome (is_marker_for) | 1.07e-03 | 22 | 65 | 2 | DOID:14250 (is_marker_for) | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 1.38e-03 | 99 | 65 | 3 | DOID:11446 (biomarker_via_orthology) | |
| Disease | colon adenocarcinoma (is_marker_for) | 1.39e-03 | 25 | 65 | 2 | DOID:234 (is_marker_for) | |
| Disease | unipolar depression, depressive symptom measurement | 1.50e-03 | 26 | 65 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | Early Pregnancy Loss | 1.81e-03 | 109 | 65 | 3 | C3830362 | |
| Disease | Miscarriage | 1.81e-03 | 109 | 65 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 1.81e-03 | 109 | 65 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 1.81e-03 | 109 | 65 | 3 | C0000822 | |
| Disease | mean reticulocyte volume | 1.85e-03 | 799 | 65 | 7 | EFO_0010701 | |
| Disease | pneumonia, COVID-19 | 2.01e-03 | 113 | 65 | 3 | EFO_0003106, MONDO_0100096 | |
| Disease | reticulocyte measurement | 2.13e-03 | 1053 | 65 | 8 | EFO_0010700 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RAFFPCFDTPAVKYK | 176 | Q9H4A4 | |
| CLNPILYAFLGAKFK | 296 | P61073 | |
| CLNPLFYGFLGKKFK | 296 | P30556 | |
| IKAGFAGDQIPKYCF | 21 | P42025 | |
| KPFFCLEKYLGGLFV | 2881 | Q86UQ4 | |
| AFPDTKKTYCFDAFP | 221 | Q96GS6 | |
| LNYKDPCKAAAFLGD | 41 | P13497 | |
| VSYFAFKFAKKDCPV | 311 | Q9NSY1 | |
| GNADGEYCKFPFLFN | 226 | P08253 | |
| EYCKFPFLFNGKEYN | 231 | P08253 | |
| RCSPKDFNKYFLTFA | 426 | O60674 | |
| ASKRDKKFFACAPNY | 491 | Q96RS6 | |
| FFCKLHFIKGNDPYC | 101 | Q8N6C7 | |
| AFFLFCSEYRPKIKG | 101 | P09429 | |
| FFAQIKGYKRCILFP | 206 | Q9NWT6 | |
| HPELKVGDYFFGKCF | 391 | Q9NZ08 | |
| TFLLYKFLKECAGEP | 1446 | Q9UIW2 | |
| KFLKECAGEPLFLLY | 1426 | P51805 | |
| LYKFLKECAGEPLFS | 1446 | Q9HCM2 | |
| KYIFPLDDKAAVCGF | 656 | Q9UKK3 | |
| CVLKGGYKFFADLLD | 66 | P00492 | |
| DLGGVKKEFFYCLFA | 721 | Q9UII4 | |
| KFEKKRYFFFGVLCG | 761 | Q9UII4 | |
| RKLYEKFLEFGPENC | 626 | Q9BZJ0 | |
| KYFNCNKEELPLFSD | 506 | Q9P2H0 | |
| LALPDFFKAFYECLA | 231 | O75718 | |
| KPEEFKKLLYGLCFF | 3571 | Q8WXX0 | |
| IKAGFAGDQIPKYCF | 21 | P61163 | |
| APCYQDYVKKFGENF | 181 | P13612 | |
| DFEYYKQFCVPGFKN | 131 | Q8IWA5 | |
| KFFLPKACLNFEFFS | 566 | P14735 | |
| LYCFQFLPFGKGLIK | 546 | Q92523 | |
| NAVCKLYFDLEFNKP | 106 | Q96LW4 | |
| KHFYFNATKGFPCLK | 276 | Q96QI5 | |
| PILYAFLDENFKACF | 316 | P41146 | |
| DTDKLFGYCPLKFEG | 201 | P22897 | |
| KPFDKFQFERLGYFS | 736 | P47897 | |
| DLAQGFNKKYGEFFP | 191 | Q9UGM6 | |
| KKYYLFGRNPDLCDF | 46 | Q12972 | |
| EKEGPSKYFFFRICH | 591 | Q4G0N8 | |
| KAGTYLCLLEKFFPD | 26 | P0CF51 | |
| KAGTYLCLLEKFFPD | 26 | P03986 | |
| NYRKAFADCDGFKIP | 286 | Q8IV61 | |
| AFFLFCSEYHPKIKG | 101 | B2RPK0 | |
| LGNVFLKFKDKFCVY | 131 | Q8TCU6 | |
| ICADGSYYKFLFNPK | 311 | Q5MNZ6 | |
| PLFDYFLKCKENGAF | 291 | P41252 | |
| FTFNDLCIKLGFPYL | 296 | Q92966 | |
| KFGKVPFDYASFDAQ | 496 | O60284 | |
| AFPDTKKTYCFDAFP | 201 | Q5VST6 | |
| DPLLRGFYFDKKSCK | 1496 | Q13023 | |
| CYDKKLEASRPDFFN | 246 | Q9H6Q4 | |
| YKGAKACFLRDIPFS | 481 | O75746 | |
| DCFKKVLRYEGFFGL | 376 | Q9UJS0 | |
| EFKGHCYRFFPLNKT | 46 | Q6UXS0 | |
| AFKACHPKIKSFYFA | 636 | Q8WXI2 | |
| FPCDKYVKVFHKFLN | 176 | Q8TF32 | |
| ANAFLKEFCLKCPEY | 926 | Q96RL7 | |
| LTDLFKPAKVGFQCY | 41 | Q6T4P5 | |
| DCFFYDGIKAIFQLG | 686 | O95759 | |
| FFLFCSEYRPKIKGE | 776 | P23497 | |
| RAGCKFKFIFQGNPY | 291 | Q9UJ04 | |
| DFCYLLDKSKQLFNG | 61 | Q8N9R8 | |
| PLFFLDYFSCGKLDL | 531 | P22102 | |
| CESPFLAKDFYKNGT | 786 | P11137 | |
| TFDYCPFLIAEKLGK | 146 | Q3SY77 | |
| FKPGFEKYNNLDLFR | 1701 | O60293 | |
| CFAPSEKFVKYLRNF | 1201 | Q13402 |